Tomoki Ito

20PUBLICATIONS
29CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pacific Peoples medicine and treatmentsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 20, 2025
A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Hiroki Yamaguchi, Masaki Iino, Shugo Kowata

|Aug 21, 2024
Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance.

Tomoki Ito, Tomohiko Kamimura, Toru Kiguchi

|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.

Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda

|Sep 11, 2023
Efficacy of Gefapixant, a P2X3 Antagonist, for Refractory Atopic Cough.

Yoshihisa Ishiura, Shosaku Nomura, Yuka Ishii

|May 31, 2023
Effects of Tofogliflozin and Anagliptin Alone or in Combination on Glucose Metabolism and Atherosclerosis-Related Markers in Patients with Type 2 Diabetes Mellitus.

Shosaku Nomura, Akira Shouzu, Takehito Taniura

Pageof 4